VP2

VP2 (PF3D7_1235200) is a type II, K⁺-independent V-type H⁺-translocating inorganic pyrophosphatase of Plasmodium falciparum, cloned and assigned to this biochemical class by sequence and phylogenetic analysis that distinguished it from the K⁺-dependent type I enzyme PfVP1 (PMID:11378198). It is dispensable for the intraerythrocytic stage: clean double-crossover disruption yields viable blood-stage parasites (PMID:21251930). Beyond its predicted role in pyrophosphate hydrolysis coupled to proton pumping, direct mechanistic characterization of the VP2 protein itself is limited in the available corpus; a preprint places it at parasite subcellular membranes acting as a proton pump within pyrophosphate homeostasis alongside PfVP1 (PMID:40027813). In P. berghei, elevated transcript levels of the VP2 ortholog accompany piperaquine and lumefantrine resistance, an association that has not been extended to a demonstrated functional role for the protein (PMID:25448357).

1. 2001 Medium

   Establishing that P. falciparum encodes a second, biochemically distinct pyrophosphatase answered whether the parasite's PPi-driven proton pumping was carried by a single enzyme, defining VP2 as a type II (K⁺-independent) counterpart to the K⁺-dependent PfVP1.

   Evidence Gene cloning, sequence analysis, and phylogenetic comparison in P. falciparum

   PMID:11378198

   Open questions at the time

   • K⁺-independence and pyrophosphatase/proton-pump activity were inferred from sequence similarity to plant AVP2, not directly assayed for VP2
   • no biochemical reconstitution of VP2 enzymatic activity
   • subcellular localization not determined at this stage
2. 2011 High

   Determining whether VP2 is required for blood-stage growth showed the gene is not essential in erythrocytic parasites, constraining its physiological importance in that stage.

   Evidence Double-crossover gene disruption with yDHODH positive and yCD-UPRT negative selection in P. falciparum blood stages

   PMID:21251930

   Open questions at the time

   • does not address a role in non-erythrocytic (mosquito or liver) stages
   • does not reveal what function VP2 serves when present
   • possible functional redundancy with PfVP1 not directly tested
3. 2014 Low

   Testing whether VP2 expression tracks with antimalarial resistance revealed elevated ortholog transcript levels in resistant lines, raising but not resolving a possible role in drug resistance.

   Evidence mRNA transcript quantification in piperaquine- and lumefantrine-resistant P. berghei ANKA lines selected in vivo

   PMID:25448357

   Open questions at the time

   • association only; no functional test of VP2 protein activity in resistance
   • shown in P. berghei ortholog, not in P. falciparum VP2
   • proposed link to digestive-vacuole proton gradients not experimentally demonstrated
4. 2025 Low

   Assigning subcellular localization and proton-pump function positioned VP2 at parasite membranes within pyrophosphate homeostasis alongside PfVP1.

   Evidence Reverse genetics and biochemical approaches in P. falciparum (preprint)

   PMID:40027813

   Open questions at the time

   • preprint provides no granular experimental detail specific to VP2
   • the study's primary focus is on soluble pyrophosphatases, not VP2
   • direct measurement of VP2 proton-pumping activity not reported

• It remains unknown what physiological role VP2 serves given its dispensability, and whether its predicted K⁺-independent pyrophosphatase/proton-pump activity is directly demonstrable and mechanistically linked to antimalarial drug resistance.
• no direct biochemical assay of VP2 pyrophosphatase or proton-pump activity
• no functional demonstration of a resistance role for VP2 itself
• stage-specific and redundancy relationships with PfVP1 uncharacterized